Table 3.

Multivariable analysis of factors predictive of the risk of death at 30 days and 6 months.

	30-day risk of death	6-month risk of death
	HR (95% CI)	HR (95% CI)
Area
Other EU	1	1
UK	1.52 (1.17–1.99)	1.41 (1.10–1.80)
Gender
Male	1	1
Female	1.09 (0.82–1.45)	1.12 (0.86–1.45)
Age
<65 years	1	1
≥65 years	1.76 (1.30–2.39)	1.60 (1.23–2.10)
Number of comorbidities
0–1	1	1
≥2	1.34 (1.02–1.76)	1.50 (1.17–1.92)
Smoking history
Never-smokers	1	1
Current/former smokers	1.18 (0.92–1.52)	1.18 (0.93–1.48)
Cancer site
Breast	0.84 (0.51–1.37)	0.84 (0.54–1.32)
Gastrointestinal	1.08 (0.74–1.57)	1.22 (0.86–1.71)
Gynaecological/genitourinary	0.89 (0.61–1.28)	0.94 (0.67–1.33)
Haematological	1.29 (0.82–2.04)	1.20 (0.78–1.85)
Lung	1	1
Other	0.86 (0.52–1.40)	0.92 (0.59–1.43)
Tumour stage
Local/locoregional	1	1
Advanced	1.56 (1.15–2.10)	1.71 (1.30–2.25)
Tumour status
Remission/non-measurable disease	1	1
Active malignancy	1.54 (1.09–2.17)	1.82 (1.32–2.51)
Anticancer therapy at COVID-19 diagnosis
No	1	1
Yes	0.81 (0.62–1.06)	0.72 (0.57–0.92)
COVID-19 therapy (any)
No	1	1
Yes	0.63 (0.48–0.84)	0.72 (0.55–0.93)
Complicated COVID-19
No	1	1
Yes	6.99 (4.61–10.62)	4.52 (3.26–6.26)

COVID-19, coronavirus disease 2019; EU, Europe; UK, United Kingdom; HR, hazard ratio; CI, confidence interval.